Menu Search
Equities

Chaoju Eye Care Holdings Ltd

2219:HKG.HS

Chaoju Eye Care Holdings Ltd

Actions
  • Price (HKD)3.43
  • Today's Change-0.150 / -4.19%
  • Shares traded5.08m
  • 1 Year change-23.78%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Chaoju Eye Care Holdings Limited is a China-based company principally engage in the provision of ophthalmic services and eye care services through hospitals and optical clinics. The Company operates its businesses through two segments. The Consumer Ophthalmic Services segment provides refractive correction (including presbyopia correction), myopia control and provides optical products and services. The Basic Ophthalmic Services segment provides treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases and pediatric eye diseases, which may be covered by public health insurance programs. The Company mainly conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)1.48bn
  • Net income in HKD247.45m
  • Incorporated2020
  • Employees2.60k
  • Location
    Chaoju Eye Care Holdings LtdBlock A, Shouke Building24/F, East Zone,No. 14 Yard, West3rd Ring South Road, Fengtai DistrictBEIJING ChinaCHN
  • Websitehttp://www.chaojueye.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.